Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Pharmaceutical Chemicals
GSK cuts 200 U.K. manufacturing jobs
by Alex Scott
October 12, 2018
| A version of this story appeared in
Volume 96, Issue 41
British pharmaceuticals major GlaxoSmithKline says it is shedding almost 200 jobs at its site in Ulverston, England, involved in the manufacture of active ingredients for sterile injections. GSK aims to make the job cuts by 2020. The move follows a 2017 review of its U.K. operations to improve the efficiency and competitiveness of its manufacturing network. The company says it will retain about 150 at the Ulverston site to produce cephalosporin antibiotics, a business the firm says is enjoying strong growth.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter